Literature DB >> 20230411

A United Kingdom Haemophilia Centre Doctors' Organization guideline approved by the British Committee for Standards in Haematology: guideline on the use of prophylactic factor VIII concentrate in children and adults with severe haemophilia A.

Michael Richards1, Michael Williams, Elizabeth Chalmers, Ri Liesner, Peter Collins, Vicky Vidler, John Hanley.   

Abstract

Consensus-based guidelines supported by the literature are presented on the role of prophylactic administration of factor VIII concentrate in children and adults with severe haemophilia A. The timing of initiation of prophylaxis, the choice of prophylactic regimen, monitoring, management of breakthrough bleeding and education of the patient and family are discussed.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20230411     DOI： 10.1111/j.1365-2141.2010.08139.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


  28 in total

1.  Bleeding before prophylaxis in severe hemophilia: paradigm shift over two decades.

Authors:  Annelies Nijdam; Carmen Altisent; Manuel D Carcao; Ana R Cid; Ségolène Claeyssens-Donadel; Karin Kurnik; Rolf Ljung; Beatrice Nolan; Pia Petrini; Helen Platokouki; Anne Rafowicz; Angela E Thomas; Kathelijn Fischer
Journal:  Haematologica       Date:  2014-12-19       Impact factor: 9.941

2.  Target of prophylaxis in severe haemophilia: more than factor levels.

Authors:  Antonio Coppola; Massimo Franchini
Journal:  Blood Transfus       Date:  2012-12-21       Impact factor: 3.443

Review 3.  Current and evolving features in the clinical management of haemophilia.

Authors:  Antonio Coppola; Massimo Morfini; Ernesto Cimino; Antonella Tufano; Anna M Cerbone; Giovanni Di Minno
Journal:  Blood Transfus       Date:  2014-04       Impact factor: 3.443

Review 4.  Efmoroctocog Alfa: A Review in Haemophilia A.

Authors:  James E Frampton
Journal:  Drugs       Date:  2016-09       Impact factor: 9.546

5.  Prophylaxis therapy in paediatric patients with haemophilia: a survey of clinical management trends in Italy.

Authors:  Giancarlo Castaman; Angiola Rocino; M Gabriella Mazzucconi; Ezio Zanon; Fabio Gagliano; Angelo C Molinari
Journal:  Blood Transfus       Date:  2015-05-14       Impact factor: 3.443

6.  Self-management and skills acquisition in boys with haemophilia.

Authors:  Kate Khair; Liz Meerabeau; Faith Gibson
Journal:  Health Expect       Date:  2013-05-27       Impact factor: 3.377

7.  Intermediate-dose versus high-dose prophylaxis for severe hemophilia: comparing outcome and costs since the 1970s.

Authors:  Kathelijn Fischer; Katarina Steen Carlsson; Pia Petrini; Margareta Holmström; Rolf Ljung; H Marijke van den Berg; Erik Berntorp
Journal:  Blood       Date:  2013-06-18       Impact factor: 22.113

8.  Haemophilia at various stages of life: design of new therapeutic strategies through an interactive course--the Kogeniale project.

Authors:  Elena Santagostino; Maria Messina; Annarita Tagliaferri; Alfonso Iorio; Massimo Morfini
Journal:  Blood Transfus       Date:  2013-01-23       Impact factor: 3.443

9.  [Treatment of haemophilia in Austria].

Authors:  Ingrid Pabinger; Max Heistinger; Wolfgang Muntean; Sylvia-Elisabeth Reitter-Pfoertner; Sabine Rosenlechner; Thomas Schindl; Gerhard Schuster; Werner Streif; Katharina Thom; Christoph Male
Journal:  Wien Klin Wochenschr       Date:  2015-11-02       Impact factor: 1.704

Review 10.  Octocog alfa, antihaemophilic factor (recombinant), plasma/albumin free method (Advate®): a review of its use in the management of patients with haemophilia A.

Authors:  Sohita Dhillon
Journal:  Drugs       Date:  2012-05-07       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.